BioSpace News Archive

Drug Screening Market: Rise in Use of Narcotics and Illicit Drugs to Propel the Global Market

Wilmington, Delaware, United States, Transparency Market Research Inc. – The increased use of drugs and alcohol, the implementation of strict laws requiring drug and alcohol testing are all contributing towards the growth of the global drug screening market in the near future.

August 17, 2022
·
6 min read
Hospital Acquired Infections Diagnostics Market: In-Depth Analysis & Forecast 2019-2027

Wilmington, Delaware, United States, Transparency Market Research Inc. – Hospital acquired infections are infections acquired in hospital or health care facility by a patient admitted for reason other than the infection.

August 17, 2022
·
6 min read
Therapeutic Ultrasound Devices Market Demand, Insights and Forecast up to 2027

Wilmington, Delaware, United States, Transparency Market Research Inc. – Therapeutic ultrasound is a type of treatment modality that is used during physical therapy to tissue, muscles, joints, tendons, and ligaments.

August 17, 2022
·
5 min read
Genetown

BioPorto Announces Interim Results for the First Six Months of 2022

BioPorto A/S announced interim financial results for the first six months of 2022 and business progress for the second quarter of 2022.

August 17, 2022
·
9 min read
JOYSBIO Has Developed New Monkeypox Rapid Tests

JOYSBIO, one of the world’s leading manufacturers of lateral flow rapid test kits, is proud to announce the development of two Monkeypox tests, both of which deliver results in 15 minutes or less.

August 17, 2022
·
2 min read
Business

Gerresheimer and Zollner enter into a strategic partnership for electronically controlled medtech systems from a single source

Gerresheimer AG and Zollner Elektronik AG are pooling their market-leading pharmaceutical and medical technology expertise under a strategic partnership.

August 17, 2022
·
3 min read
Genetown

Viridian Therapeutics Announces Pricing of Upsized Public Offering of Shares of Common Stock and Preferred Stock - Aug 17, 2022

Viridian Therapeutics, Inc., a biotechnology company advancing new treatments for patients suffering from serious diseases underserved by current therapies, announced the pricing of an upsized underwritten public offering with gross proceeds of approximately $270 million.

August 17, 2022
·
5 min read
Business

Mallinckrodt Announces Appointment of Karen Ling to Its Board of Directors

Mallinckrodt plc, a global specialty pharmaceutical company, announced that Karen Ling has been appointed to the Company’s Board of Directors, effective August 12, 2022.

August 17, 2022
·
5 min read
Genetown

Blueprint Medicines Announces Positive Top-line Results from PIONEER Trial of AYVAKIT® (avapritinib) in Patients with Non-Advanced Systemic Mastocytosis Achieving Primary and All Key Secondary Endpoints

Blueprint Medicines Corporation (NASDAQ: BPMC) today announced positive top-line results from the registrational Part 2 of the PIONEER clinical trial of AYVAKIT®.

August 17, 2022
·
15 min read
Drug Development

Arrowhead Files for Regulatory Clearance to Initiate Phase 1/2a Study of ARO-MMP7 for Idiopathic Pulmonary Fibrosis

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it has filed an application for clearance to initiate a Phase 1/2a clinical trial of ARO-MMP7, the company’s investigational RNA interference (RNAi) therapeutic designed to reduce expression of matrix metalloproteinase 7 (MMP7) as a potential treatment for idiopathic pulmonary fibrosis (IPF).

August 17, 2022
·
4 min read